ArticlePLOS global public health2025
Factors associated with HIV infection and the utilization of HIV testing services among transgender people in Georgia.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Barriers and facilitators to HIV testing among transgender people in Georgia: Qualitative study results using the COM-B Framework.PLOS global public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
We assessed factors associated with HIV infection as well as the utilization of HIV testing among transgender people (TGs) in the country of Georgia. From July 2020 to January 2021, TG participants were recruited using snowball sampling in three major Georgian cities: Tbilisi, Batumi and Kutaisi. The participants underwent structured face‒to-face interviews and rapid tests for HIV. The study employed descriptive analyses, and bivariate and multivariable logistic regression to explore factors associated with HIV infection and HIV testing history. Of the 95 participants, 49.5% identified as transgender women, 7.3% as transgender men, and 43.2% as non-binary individuals, with a mean age of 27.24 years (SD = 8.52). Overall, HIV prevalence was 24.1%, with transgender women experiencing the highest burden (40.5%). HIV prevalence was higher among transgender women (40.5%) and those involved into commercial sex work (41.7%), however, none of the predictor variables reached the level of significance in adjusted model. HIV testing in the past six months were reported by 76.8% of participants and predictors for testing were living alone (aOR=5.9, 95% CI: 1.06-32.69) and experiences of enacted stigma (aOR=1.76, 95% CI: 1.04-2.97). Conclusion: Our study reveals a high HIV burden among transgender individuals in Georgia, particularly transgender women. This is combined with significant gaps in the utilization of HIV prevention services. Further research is needed to explore the intersection of stigma and other barriers affecting a low uptake of HIV testing to inform the development of effective targeted interventions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.